Aspect Analytics
Founded 2018 · 29 employees on LinkedIn · 6 known investors
Aspect Analytics develops computational infrastructure for spatial biology analysis, enabling scientists to extract actionable insight from multimodal biological data to accelerate drug development. The company combines spatial omics, imaging analysis, and machine learning to help research teams understand tissue architecture and disease mechanisms.
Investors · 6
Also in the syndicate · 3
Capricorn PartnersleadGemma Frisius FundKU Leuven
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ASep 2025
Capricorn Partners (lead), PMV (lead), Gemma Frisius Fund, Heran Partners, KU Leuven
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Aspect Analytics do?
- Aspect Analytics develops computational infrastructure for spatial biology analysis, enabling scientists to extract actionable insight from multimodal biological data to accelerate drug development. The company combines spatial omics, imaging analysis, and machine learning to help research teams understand tissue architecture and disease mechanisms.
- Who are Aspect Analytics's investors?
- Aspect Analytics's investors include Capricorn Venture Partners, Heran Partners, PMV.